“…Indeed, LVR represents an important predictor of mortality and HF after MI [45]. Weir et al first explored the relationship between Gal-3 and LVR concluding that elevated baseline plasma Gal-3 levels are associated with lower left ventricular ejection fraction (LVEF), a wellknown indicator of poor outcome being associated to adverse LVR, at 24-weeks follow-up, but no at baseline, in patients with MI [34]. In the same year, Tsai et al showed a significant inverse correlation between Gal-3 and LVEF in STEMI patients treated by pPCI [33].…”